Glen Harbor Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$8.44M Buy
178,920
+78,596
+78% +$3.59M 0.18% 117
2019
Q2
$4.72M Buy
100,324
+26,488
+36% +$1.22M 0.1% 197
2019
Q1
$3.56M Sell
73,836
-12,208
-14% -$612K 0.08% 235
2018
Q4
$3.84M Sell
86,044
-17,696
-17% -$922K 0.09% 217
2018
Q3
$5.6M Sell
103,740
-924
-0.9% -$47.3K 0.11% 180
2018
Q2
$5.11M Sell
104,664
-5,964
-5% -$338K 0.11% 187
2018
Q1
$6.93M Buy
110,628
+32,536
+42% +$2.23M 0.16% 135
2017
Q4
$4.79M Buy
78,092
+35,784
+85% +$2.21M 0.11% 176
2017
Q3
$2.83M Sell
42,308
-6,356
-13% -$449K 0.07% 244
2017
Q2
$3.79M Sell
48,664
-34,748
-42% -$2.62M 0.09% 196
2017
Q1
$6.8M Sell
83,412
-13,748
-14% -$1.08M 0.17% 111
2016
Q4
$6.99M Buy
+97,160
New +$7.02M 0.19% 103

Other funds holding CAH

Glen Harbor Capital Management's CAH Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Cardinal Health (CAH) stake by 78% in Q3 2019, buying an estimated $3.59M and bringing the position to 178,920 shares worth $8.44M. The position accounts for 0.18% of the portfolio, ranked #117.

Glen Harbor Capital Management first reported a position in CAH in Q4 2016 and has held it in 12 quarters since. 664 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

  • Glen Harbor Capital Management held 178,920 shares of Cardinal Health worth $8.44M as of Q3 2019.
  • Glen Harbor Capital Management bought 78,596 Cardinal Health shares in Q3 2019, an estimated $3.59M.
  • Cardinal Health made up 0.18% of Glen Harbor Capital Management's portfolio in Q3 2019, its #117 holding.
  • Glen Harbor Capital Management first reported a position in Cardinal Health in Q4 2016 and has held it in 12 quarters since.
  • 664 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.